Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Business

Agreement Enlarges China's Role in Cancer Immunotherapeutics Development

A recent agreement marks the expansion of drug development collaboration between a Chinese biopharmaceutical company and a major international drug corporation.   More...
26 Oct 2015

Research Institutes Partner to Develop a Global Center for Transformative Nanomedicine

Two internationally renowned biomedical research institutions have agreed to collaborate in the establishment of a virtual center to boost development of nanotechnological techniques for diagnosis and treatment of disease.   More...
25 Oct 2015
Image: A Vetter aseptically pre-filled syringe (Photo courtesy of Vetter).

German Prefilled Syringe Manufacturer to Double Production Capability

A major manufacturer of pre-filled sterile syringes, cartridges, and vials will be investing approximately EUR 300 million to expand and upgrade its manufacturing facilities over an estimated five-year period.  More...
18 Oct 2015

Sale of Mexican Pharmaceutical Company Expected to Boost Latin American Prescription Drug Market

The sale of a major Mexican pharmaceutical company to an international generic drug corporation is expected to accelerate the growth of the Latin American market for prescription drugs.  More...
11 Oct 2015

Collaboration Agreement to Boost Discovery of Fully Human Antibodies for Therapeutic Use

The discovery of fully human antibodies for therapeutic use will be boosted by a recently announced collaboration between a major university research center and a dynamic biopharmaceutical development company.  More...
04 Oct 2015

Biopharmaceutical Partners Seek Alternatives to Glucocorticoid Steroid Drugs

Collaboration between American and Japanese biopharmaceutical companies is expected to lead to the development of a new class of small molecule drugs for treatment of hematological and inflammatory diseases.  More...
28 Sep 2015

Collaboration to Promote Development of Bispecific Antibody Therapeutics for Cancer and Inflammation

Two biomedical development companies have agreed to a joint program to promote research and commercialization of bispecific monoclonal antibodies for immunotherapy of cancer and inflammation.  More...
27 Sep 2015


BioResearch Industry News channel updates the reader on mergers and takeovers, on cooperative agreements and on trends in the biotech industry worldwide.
Copyright © 2000-2016 Globetech Media. All rights reserved.